Results 191 to 200 of about 721,847 (303)

Intravascular Ultrasound in Chronic Limb‐Threatening Ischemia Endovascular Revascularization: A Multidisciplinary Survey of Clinical Practices and Operator Perceptions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Intravascular ultrasound (IVUS) may be beneficial for guiding endovascular revascularization in patients with chronic limb‐threatening ischemia (CLTI); however, its use remains limited. Methods We surveyed interventional radiologists, vascular surgeons, and interventional cardiologists in the United States, Canada, and the United ...
Marc‐André d'Entremont, Eric A. Secemsky, Graham R. McClure, Krzysztof Kowalik, Laura M. Drudi, Samuel Lemaire‐Paquette, Andrew D. Brown, Elisa Greco, Andrew Benko, Anirudh Mirakhur, Elie Girsowicz, Jane Newman, Jonathan Misskey, Simon Bérubé, John Harlock, Sanjit S. Jolly   +15 more
wiley   +1 more source

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Atherosclerosis, 2011
A. Catapano, Željko Reiner, Guy G. De Backer, Ian Graham, M. Taskinen, Olov Wiklund, S. Agewall, Eduardo Alegría, M. J. Chapman, P. Durrington, S. Erdine, J. Halcox, Richard J. Hobbs, J. Kjekshus, Pasquale Perrone Filardi, G. Riccardi, Robert F. Storey, David A. Wood   +17 more
semanticscholar   +1 more source

Clinical and Echocardiographic Outcomes After Implantation of the ALLEGRA Transcatheter Valve Using the Fully Repositionable IMPERIA Delivery System: One‐Year Results of the EMPIRE I Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz, Claire B. Ren, Christof Burgdorf, Christian Frerker, Ignacio Cruz‐González, Joan Antoni Gómez, José Maria Hernândez, Pilar Jimenez, Ernest Spitzer, Pim Tonino, Pieter Vriesendorp, Nicolas van Mieghem, Samuel Copt, Anders Jönsson, Keith G. Oldroyd, Nicolas Doll   +15 more
wiley   +1 more source

Tracing the evolution of cardiology: Pioneering discoveries and paradigm shifts in cardiovascular care. [PDF]

Am Heart J Plus
Shukla K, Natalie A, Peters M, Bracewell N.   +3 more
europepmc   +1 more source

Journal of the American College of Cardiology

Evidence from cohort studies and a randomized clinical trial indicates that annual vaccination against seasonal influenza prevents cardiovascular morbidity and all-cause mortality in patients with cardiovascular conditions. The American Heart Association

core  

Genetics in Cardiology

The Anatolian Journal of Cardiology, 2023
openaire   +3 more sources

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer, Thomas J. Stocker, Ludwig T. Weckbach, Julia Novotny, Philipp M. Doldi, Hannah Kempton, Steffen Massberg, Michael Näbauer, Jörg Hausleiter, Lukas Stolz   +9 more
wiley   +1 more source

Role of Neuroimaging Before Coronary Angiography in Patients With Out‐of‐Hospital Cardiac Arrest

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Patients presenting following out‐of‐hospital cardiac arrest (OOHCA) often require emergency coronary angiography. Presentations can be associated with syncope or head‐trauma. Aims We investigated the impact and utility of pre‐coronary angiography CT‐Brain (CT‐B) in patients following OOHCA on clinical outcomes.
Edmond Wong, Kathryn Yu, Davide Tomassoni, Timothy Scully, Timothy Yeung, Jennifer Cooke, David Tong, Jaya Chandrasekhar, Jason Nogic   +8 more
wiley   +1 more source

Cardio-Obstetrics Fundamentals for Fellows: A Digital Solution for Democratizing Cardio-Obstetric Education. [PDF]

JACC Adv
Sarma A, Hameed AB, Economy K, Scott NS, Harrington CM, Valente AM, Prabhu M, Wolfe D, Davis MB, DeFaria Yeh D.   +9 more
europepmc   +1 more source

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention

Clinical Pharmacology &Therapeutics, EarlyView.
CYP2C19 and CYP3A4 contribute to clopidogrel bioactivation. CYP2C19 no‐function alleles diminish clopidogrel's antiplatelet effects and clinical effectiveness. Coadministration of either a CYP2C19 or a CYP3A4 inhibitor may also reduce clopidogrel's antiplatelet effects and lead to phenoconversion in patients without a CYP2C19 no‐function allele (normal/
Danwei Shao, Jean G. Malavé, Joseph S. Rossi, Francesco Franchi, Ellen C. Keeley, Dominick J. Angiolillo, George A. Stouffer, Larisa H. Cavallari, Craig R. Lee   +8 more
wiley   +1 more source